Sarah Cannon Cancer Center at TriStar is the Nashville home of Sarah Cannon, the Cancer Institute of HCA Healthcare and one of the world's leading oncology programs. Dedicated entirely to cancer care, the center brings together medical oncologists, surgical oncologists, radiation oncologists, oncology nurses, pharmacists, social workers, and patient navigators — all focused exclusively on delivering the most advanced cancer treatments available. Sarah Cannon is globally recognized for its clinical research program — conducting more Phase I, II, and III oncology clinical trials than virtually any other program in the world. This gives patients access to experimental treatments and next-generation therapies not yet available anywhere else, including novel immunotherapies, targeted agents, antibody-drug conjugates, and CAR-T cell therapies for hematologic malignancies. The center offers comprehensive, multidisciplinary tumor boards for all major cancer types — breast, lung, colorectal, pancreatic, hematologic, genitourinary, gynecologic, head and neck, and sarcoma. Precision oncology through molecular profiling of each patient's tumor identifies the most effective targeted therapy or trial opportunity. A full supportive care team — including palliative care, financial navigation, nutritional counseling, and cancer rehabilitation — supports patients through every phase of their cancer journey.
